KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Common Equity (2016 - 2025)

Historic Common Equity for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $1.1 billion.

  • Chemed's Common Equity fell 1287.25% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 1287.25%. This contributed to the annual value of $1.1 billion for FY2024, which is 100.35% up from last year.
  • As of Q3 2025, Chemed's Common Equity stood at $1.1 billion, which was down 1287.25% from $1.2 billion recorded in Q2 2025.
  • Chemed's 5-year Common Equity high stood at $1.2 billion for Q3 2024, and its period low was $623.3 million during Q4 2021.
  • In the last 5 years, Chemed's Common Equity had a median value of $952.1 million in 2023 and averaged $959.8 million.
  • In the last 5 years, Chemed's Common Equity crashed by 3083.97% in 2021 and then surged by 4128.37% in 2023.
  • Over the past 5 years, Chemed's Common Equity (Quarter) stood at $623.3 million in 2021, then increased by 28.15% to $798.7 million in 2022, then surged by 38.71% to $1.1 billion in 2023, then rose by 1.0% to $1.1 billion in 2024, then decreased by 3.78% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q3 2025, $1.2 billion for Q2 2025, and $1.2 billion during Q1 2025.